Decreased irisin secretion contributes to muscle insulin resistance in high-fat diet mice

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 6, 2015, Pages 6490-6497

  Yang, Zaigang ^a   Chen, Xu ^a   Chen, Yujuan ^a   Zhao, Qian ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Diabetes; High fat diet; Irisin; Muscle insulin resistance; Obesity

Indexed keywords

BIOLOGICAL MARKER; FIBRONECTIN; FNDC5 PROTEIN, MOUSE; GLUCOSE BLOOD LEVEL; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PALMITIC ACID; PROTEIN KINASE B; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ANIMAL; BLOOD; C57BL MOUSE; CELL LINE; COMPLICATION; DIABETES MELLITUS, TYPE 2; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; GENETICS; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; METABOLISM; OBESITY; PARACRINE SIGNALING; SECRETION (PROCESS); SKELETAL MUSCLE; TIME FACTOR;

ADIPOSE TISSUE; ANIMALS; BIOMARKERS; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBRONECTINS; INSULIN; INSULIN RESISTANCE; MICE, INBRED C57BL; MUSCLE, SKELETAL; OBESITY; PALMITIC ACID; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS C-AKT; TIME FACTORS; TRIGLYCERIDES;

EID: 84938634780     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. De Angelis K, Irigoyen MC and Morris M. Diabetes and cardiovascular autonomic dysfunction: application of animal models. Auton Neurosci 2009; 145: 3-10.
2. Sander HW and Chokroverty S. Diabetic amyotrophy: current concepts. Semin Neurol 1996; 16: 173-178.
3. Lazar MA. How obesity causes diabetes: not a tall tale. Science 2005; 307: 373-375.
4. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS and Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-79.
5. Gesta S, Tseng YH and Kahn CR. Developmental origin of fat: tracking obesity to its source. Cell 2007; 131: 242-256.
6. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473-486.
7. Amitani M, Asakawa A, Amitani H and Inui A. The role of leptin in the control of insulin-glucose axis. Front Neurosci 2013; 7: 51.
8. Kahn BB and Flier JS. Obesity and insulin resistance. J Clin Invest 2000; 106: 473-481.
9. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP and Spiegelman BM. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-468.
10. Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, Srbecky M, Imrich R, Kyselovicova O, Belan V, Jelok I, Wolfrum C, Klimes I, Krssak M, Zemkova E, Gasperikova D, Ukropec J and Ukropcova B. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol 2014; 592: 1091-1107.
11. Xiang L, Xiang G, Yue L, Zhang J and Zhao L. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Atherosclerosis 2014; 235: 328-333.
12. Alis R, Sanchis-Gomar F, Pareja-Galeano H, Hernandez-Mijares A, Romagnoli M, Victor VM and Rocha M. Association between irisin and homocysteine in euglycemic and diabetic subjects. Clin Biochem 2014; 47: 333-335.
13. Crujeiras AB, Zulet MA, Lopez-Legarrea P, de la Iglesia R, Pardo M, Carreira MC, Martinez JA and Casanueva FF. Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients. Metabolism 2014; 63: 520-531.
14. Song H, Wu F, Zhang Y, Zhang Y, Wang F, Jiang M, Wang Z, Zhang M, Li S, Yang L, Wang XL, Cui. and Tang D. Irisin promotes human umbilical vein endothelial cell proliferation through the ERK signaling pathway and partly suppresses high glucose-induced apoptosis. PLoS One 2014; 9: e110273.
15. Zhang Y, Li R, Meng Y, Li S, Donelan W, Zhao Y, Qi L, Zhang M, Wang X, Cui T, Yang LJ and Tang D. Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 2014; 63: 514-525.
16. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE and Mantzoros CS. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 2012; 61: 1725-1738.
17. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P and Klapp BF. Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity--correlation with body mass index. Peptides 2013; 39: 125-130.
18. Vaughan RA, Gannon NP, Barberena MA, Garcia-Smith R, Bisoffi M, Mermier CM, Conn CA and Trujillo KA. Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes Metab 2014; 16: 711-718.
19. Romanatto T, Cesquini M, Amaral ME, Roman EA, Moraes JC, Torsoni MA, Cruz-Neto AP and Velloso LA. TNF-alpha acts in the hypothalamus inhibiting food intake and increasing the respiratory quotient--effects on leptin and insulin signaling pathways. Peptides 2007; 28: 1050-1058.
20. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N, Ohtsuka-Kowatari N, Kumagai K, Sakamoto K, Kobayashi M, Yamauchi T, Ueki K, Oishi Y, Nishimura S, Manabe I, Hashimoto H, Ohnishi Y, Ogata H, Tokuyama K, Tsunoda M, Ide T, Murakami K, Nagai R and Kadowaki T. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006; 281: 26602-26614.
21. Schmittgen TD and Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008; 3: 1101-1108.
22. Roca-Rivada A, Castelao C, Senin LL, Landrove MO, Baltar J, Belen Crujeiras A, Seoane LM, Casanueva FF and Pardo M. FNDC5/irisin is not only a myokine but also an adipokine. PLoS One 2013; 8: e60563.
23. Carvalheira JB, Torsoni MA, Ueno M, Amaral ME, Araujo EP, Velloso LA, Gontijo JA and Saad MJ. Cross-talk between the insulin and leptin signaling systems in rat hypothalamus. Obes Res 2005; 13: 48-57.
24. Hirabara SM, Curi R and Maechler P. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. J Cell Physiol 2010; 222: 187-194.
25. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC and Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 2004; 287: R943-949.
26. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA and Feinglos MN. Diet-induced type II diabetes in C57BL/6J mice. Diabetes 1988; 37: 1163-1167.
27. Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E, Pardo G, Tinahones F, Ricart W and Fernandez-Real JM. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013; 98: E769-778.
28. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ and Storlien LH. Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 1991; 40: 1397-1403.
29. Petersen KF and Shulman GI. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 2002; 90: 11G-18G.